Blend Labs Beats Q2 Guidance, Launches Autopilot, and Sets Q3 Revenue at $31.5M–$33.5M
BLND sits 45% above its 52-week low of $1.175.
Summary
Blend Labs reported Q2 2026 results above guidance, launched its Autopilot product with six lenders, and provided Q3 guidance showing continued revenue growth and profitability. The company also repurchased $18.2 million in shares during the quarter.
Key Events · Earnings and Guidance · BLND
-
Q2 Results Beat Guidance
Revenue of $33.8M was near the high end of guidance, and non-GAAP operating income of $7.0M exceeded the high end. GAAP operating loss narrowed to $1.6M from $4.8M a year ago.
-
Autopilot Launch with Six Lenders
Autopilot became commercially available on July 1, 2026, and six lenders have already signed on. The company added or expanded 14 customer relationships in Q2, including six deals with Autopilot.
-
Share Repurchases Continue
Blend repurchased 11.0 million shares for $18.2M in Q2, with $13.2M remaining on the existing authorization. This follows $18.6M in repurchases in Q1.
-
Q3 Guidance: Revenue $31.5M–$33.5M
The company guided Q3 revenue of $31.5M–$33.5M and non-GAAP operating income of $3.5M–$4.5M, implying continued year-over-year growth and profitability.
Analysis · BLND · Technology
Blend Labs delivered Q2 revenue near the high end and non-GAAP operating income above the high end of its guidance, while launching its Autopilot product with six lenders already signed. The company also repurchased 11 million shares for $18.2 million, leaving $13.2 million on its buyback authorization. Q3 guidance calls for revenue of $31.5–$33.5 million and non-GAAP operating income of $3.5–$4.5 million, signaling continued operational improvement. The results and product launch are material for a company with a market cap around $472 million, especially given the recent insider accumulation and ongoing material weaknesses noted in the concurrent 10-Q.
At the time of this filing, BLND was trading at $1.70 on NYSE in the Technology sector, with a market capitalization of approximately $472.1M. The 52-week trading range was $1.18 to $4.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.